Experimental gene injection aims to save limbs from amputation
NCT ID NCT01064440
Summary
This study tested whether injections of an experimental drug called VM202 (Engensis) into the calf muscle could help people with severe blockages in their leg arteries, a condition called critical limb ischemia. The goal was to see if the drug could safely promote new blood vessel growth, improve blood flow, reduce pain, and help prevent the need for leg amputation. The trial involved 52 participants and compared the drug against a placebo injection.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CRITICAL LIMB ISCHEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Boston University School of Medicine
Boston, Massachusetts, 02118, United States
-
Cardiology PC
Birmingham, Alabama, 35211, United States
-
Ewha Womans University Medical Center
Seoul, YangCheon-ku, 158-710, South Korea
-
Jobst Vascular
Toledo, Ohio, 43506, United States
-
Northwestern Memorial Hospital
Chicago, Illinois, 60611, United States
-
Saint Louis University
St Louis, Missouri, 63110, United States
-
Seoul National University
Seoul, Jongno-gu, 110-744, South Korea
-
St. Vincent Medical Group
Indianapolis, Indiana, 46290, United States
-
Texas Heart Institute
Houston, Texas, 77030, United States
-
The Methodist Hospital
Houston, Texas, 77030, United States
-
UNC School of Medicine
Chapel Hill, North Carolina, 27599, United States
-
University of Minnesota
Minneapolis, Minnesota, 55454, United States
-
University of Oklahoma HSC
Oklahoma City, Oklahoma, 73104, United States
-
University of Utah
Salt Lake City, Utah, 84132, United States
-
Vascular and Interventional Specialist of Orange County
Orange, California, 92868, United States
-
Yonsei University Health System. Severance Cardiovascular Hospital
Seoul, Seodaemun-gu, 120-752, South Korea
Conditions
Explore the condition pages connected to this study.